GEFITINIB TABLETS

GEFITINIB TABLETS Specification

Dosage Form
Tablet

Indication
Non-Small Cell Lung Cancer (NSCLC)

Salt Composition
Gefitinib

Feature
Targeted Therapy for Cancer, Oral Administration

Ingredients
Gefitinib

Application
Cancer Treatment

Physical Color/Texture
Tablet, Color: Not Specified (Usually white or off-white)

Storage Instructions
Store in a cool, dry place away from sunlight

Shelf Life
Check package for expiry, commonly 2-3 years

Intake Route
Oral

Administration Frequency
Once daily or as directed by physician

Intended Patients
Adult patients with advanced or metastatic NSCLC

Strength
250 mg

Packaging Type
Boxed Blister Pack

Prescription/Non-Prescription
Prescription

Manufactured by
GEFLIEVA/Generic Manufacturer

Other information
Keep out of reach of children; use only under medical supervision.

Brand Name
ALLIEVA

GEFITINIB TABLETS Trade Information

Minimum Order Quantity
1 Dozen

Main Export Market(s)
Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa

About GEFITINIB TABLETS

Discover the new, commanding ALLIEVA (Gefitinib Tablets 250 mg), crafted for adult cancer patients battling advanced or metastatic NSCLC. This noble, targeted therapy offers a breathtaking stride in cancer care, available exclusively by prescription and designed for convenient oral intake. Each boxed blister pack ensures lasting efficacy with proper storage. Buy the assurance of quality from India's trusted exporter and supplier network. Use strictly under medical supervision. Experience the ephemeral difference a potent, expertly formulated treatment can make in your cancer journey.

Primary Competitive Advantages & Intended Usage

ALLIEVA Gefitinib Tablets provide a powerful advantage with oral administration, enabling adult NSCLC patients to manage treatment at home. With once-daily dosing, patients experience targeted therapy, which may reduce some side effects compared to traditional chemotherapy. Used primarily under the care of oncologists, ALLIEVA ensures precise, regulated dosage for effective cancer management. Its readily accessible boxed blister packaging supports pharmacy dispensing and patient convenience, establishing it as a preferred choice among healthcare professionals and distributors alike.

Certifications, Packaging, and Payment Terms

Our Gefitinib Tablets adhere to essential pharmaceutical certifications, aligning with India's regulatory and quality standards. Securely packaged in boxed blister packs to safeguard product integrity, each shipment includes clear expiry and storage details. Payment is accepted via standard terms, reflecting competitive list prices and transparent rates. Reliable transport services ensure safe and timely delivery nationwide and internationally, meeting the logistics needs of wholesalers and traders committed to maintaining medicine quality throughout the supply chain.

FAQ's of GEFITINIB TABLETS:

Q: How should ALLIEVA Gefitinib Tablets be taken for optimal results?

A: ALLIEVA Gefitinib Tablets should be taken orally once daily or as directed by your physician. Ensure you follow your doctor's guidance and take the medication at the same time each day for consistent therapeutic effect.

Q: What is the primary usage of Gefitinib 250 mg tablets?

A: Gefitinib 250 mg tablets are primarily indicated for the treatment of adults with advanced or metastatic Non-Small Cell Lung Cancer (NSCLC) as a targeted therapy option, improving patient quality of life during cancer management.

Q: Where should I store ALLIEVA Gefitinib Tablets?

A: Store ALLIEVA Gefitinib Tablets in a cool, dry place away from sunlight. Keep the medication out of reach of children and always check the package for specific storage instructions and expiry date.

Q: What certifications ensure the quality of ALLIEVA Tablets?

A: ALLIEVA Gefitinib Tablets comply with established pharmaceutical standards and certifications as mandated by Indian health authorities, assuring quality, safety, and efficacy in every batch.

Q: What are the packaging details and available quantities for distributors?

A: ALLIEVA Gefitinib Tablets are supplied in sturdy boxed blister packs, facilitating ease of handling and distribution. Quantities can be tailored to suit wholesalers, exporters, and traders, according to demand.

Q: Who can benefit from ALLIEVA Gefitinib Tablets?

A: Adult patients diagnosed with advanced or metastatic NSCLC stand to benefit most from ALLIEVA Gefitinib Tablets, as prescribed by oncologists to specifically target cancer cells while minimizing systemic side effects.

Tell us about your requirement